Silvia Dellapasqua, MD
European Istitute of Oncology · European Institute of Oncology,Milan,Italy · European Institute of Oncology, Milano (Italy)
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Silvia Dellapasqua, MD as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 13:02 UTC. Open this list on ClinicalTrials.gov
- N/ANCT06422949 · Efficacy and Safety of HILOTERM® Device for the Prevention of Peripheral NeuropathyEuropean Institute of Oncology · not yet recruiting · Breast Cancer, Neuropathy;Peripheral · principal investigator
- Ph2NCT02005887 · TRial on the Endocrine Activity of Neoadjuvant DegarelixETOP IBCSG Partners Foundation · completed · Breast Cancer Invasive Nos · study chair
- Ph3NCT00296010 · Liposomal Doxorubicin Compared With Observation or Cyclophosphamide and Methotrexate in Treating Older Women Who Have Undergone Surgery for Breast CancerETOP IBCSG Partners Foundation · terminated · Breast Cancer · study chair
Grants
NIH projects from RePORTER, fetched 2026-11-12 13:02 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in breast cancer.